1,7-phenanthroline has been researched along with B-Cell Leukemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bushkin, Y; Demaria, S; Gottesman, SR; Schwab, R | 1 |
1 other study(ies) available for 1,7-phenanthroline and B-Cell Leukemia
Article | Year |
---|---|
Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease.
Topics: Antigens, CD; Antigens, Differentiation, B-Lymphocyte; beta 2-Microglobulin; CD4 Antigens; Flow Cytometry; Histocompatibility Antigens Class I; HLA-DR Antigens; Humans; Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, T-Cell; Macromolecular Substances; Metalloendopeptidases; Phenanthrolines; Receptors, Transferrin; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Zinc | 1994 |